Prostate cancer treatment is not a one-size-fits-all approach. Factors like patient preference, medical history, and genetic testing play crucial roles in guiding personalized care. Dr. Kristen Scarpato highlights the importance of considering genetic testing to tailor treatments for each individual patient, ensuring a more targeted and effective approach to managing prostate cancer. Read more about […]
Category: synthetic lethality in cancer
Developing UAE’s First Homegrown Cancer Drug
In the pursuit of creating the UAE’s inaugural homegrown cancer drug, Insilico’s lead candidate, Rentosertib, exhibited positive outcomes in a Phase IIa trial for idiopathic pulmonary fibrosis. Rentosertib displayed promising safety, tolerability, and early efficacy signals, showcasing potential as a breakthrough treatment option for this serious lung disease characterized by lung scarring. Read more about […]
